Results 21 to 30 of about 239,927 (172)

Bilateral leukocoria in infant with afibrinogenemia

Clinical Ophthalmology, 2008
M Necati Demir1, Mehmet Akif Acar1, Yusuf Ziya Aral2, Nurten Ünlü11Ankara Education and Research Hospital, Department of Ophthalmology, Ankara, Turkey; 2Aydin Menderes University, Faculty of Medicine, Department of Pediatric Hematology,
M Necati Demir, Mehmet Akif Acar, Yusuf Ziya Aral, Nurten Ünlü   +3 more
doaj   +1 more source

A Rare Complication of Congenital Afibrinogenemia: Bone Cysts [PDF]

Turkish Journal of Hematology, 2017
Ali Fettah, Dilek Gürlek Gökçebay, Vildan Çulha, Neşe Yaralı, Bahattin Tunç, Namık Özbek   +5 more
doaj   +2 more sources

Impaired factor XIII activation in patients with congenital afibrinogenemia [PDF]

Haematologica, 2019
Françoise Bridey, Claude Négrier, Cedric Duval, Robert Ariëns, Philippe de Moerloose, Alessandro Casini   +5 more
doaj   +2 more sources

Correction to "A Case of Congenital Afibrinogenemia With Multiple Thrombotic and Hemorrhagic Disorders". [PDF]

Clin Case Rep
Clinical Case Reports, Volume 12, Issue 11, November 2024.
europepmc   +2 more sources

Congenital Afibrinogenemia With Facial Haematoma. [PDF]

Cureus
Congenital afibrinogenemia is a rare inherited blood disorder characterized by a deficiency of fibrinogen, leading to abnormal blood clotting. It is caused by mutations in fibrinogen genes and results in a propensity for bleeding. We present the case of a one-year-old male child with congenital afibrinogenemia who developed a left-sided facial ...
Hassan M, Khan M, Ghulam M, Anthony N, Khan M.   +4 more
europepmc   +3 more sources

A Case of Congenital Afibrinogenemia [PDF]

Blood, 1957
Abstract 1. A case of congenital afibrinogenemia of a Sinhalese boy of 22 years is reported. 2. The main features of the reported cases are reviewed. 3. The principal features of this case are total absence of fibrinogen in the blood, complete non-coagulability of blood, history of several episodes of ...
P B, FERNANDO, B D, DHARMASENA
openaire   +2 more sources

Hereditary afibrinogenemia: A literature review and clinical observations [PDF]

Терапевтический архив, 2016
Afibrinogenemia is a rare congenital coagulopathy that leads to life-threatening bleeding. In afibrinogenemia, plasma fibrinogen levels are less than 0.1 g/L.
E V Yakovleva, V L Surin, D S Selivanova, A M Sergeeva, M V Gonсharova, E Yu Demidova, N P Soboleva, S A Makhinya, A V Dezhenkova, E A Likhacheva, N I Zozulya   +10 more
doaj   +1 more source

Real‐World Experience with a Human Fibrinogen Concentrate: Clinical Data from Adult and Pediatric Patients Requiring Fibrinogen for Bleeding Control and Prevention

The Journal of Clinical Pharmacology, Volume 63, Issue 11, Page 1186-1196, November 2023., 2023
Abstract Human fibrinogen concentrate (Fibryga) received temporary approval for fibrinogen replacement therapy in France (2017), with subsequent full approval for congenital and acquired hypofibrinogenemia. We evaluated real‐world use for on‐demand treatment of bleeding and prophylaxis to enhance our knowledge on fibrinogen concentrate as an option for
Francois Stéphan, Loriane Gutermann, Stéphanie Bourget, Sarah Djabarouti, Johanna Berdugo, Yann Fardini, Pierre Clerson, Guillaume Hébert, Chafké Belmokhtar   +8 more
wiley   +1 more source

Congenital fibrinogen disorders: Strengthening genotype–phenotype correlations through novel genetic diagnostic tools

British Journal of Haematology, Volume 203, Issue 3, Page 355-368, November 2023., 2023
Summary Congenital fibrinogen disorders or CFDs are heterogenous, both in clinical manifestation and array of culprit molecular lesions. Correlations between phenotype and genotype remain poorly defined. This review examines the genetic landscape discovered to date for this rare condition.
Radha Ramanan, James D. McFadyen, Andrew C. Perkins, Huyen A. Tran   +3 more
wiley   +1 more source

Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study

Health Science Reports, Volume 6, Issue 9, September 2023., 2023
Abstract Background and Aims The FORMA‐05 study compared the efficacy and safety of human fibrinogen concentrate (HFC) versus cryoprecipitate for hemostasis in bleeding patients undergoing cytoreductive surgery for pseudomyxoma peritonei (PMP). This subanalysis explores coagulation parameters in the FORMA‐05 patients, with a focus on the seven patients
Ashok Roy, Nigel Sargant, John Bell, Sophia Stanford, Cristina Solomon, Irina Kruzhkova, Sigurd Knaub, Faheez Mohamed   +7 more
wiley   +1 more source